News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Avicanna Expands its Partnership with Viola Brands to the United Kingdom
Wednesday, February 08, 2023Avicanna Inc a biopharmaceutical company focused on the development manufacturing and commercialization of plantderived cannabinoidbased products is pleased to announce that it has entered into a new sublicense agreement with VB Brands California LLC...
Addex Strategic Partner Completes Enrollment in ADX71149 Epilepsy Phase 2 Study Part 1
Tuesday, February 07, 2023Addex Therapeutics a clinicalstage pharmaceutical company pioneering allosteric modulationbased drug discovery and development today announced that enrollment into Part of the Phase clinical study of ADX JNJ for the treatment of epilepsy has been c...
Alvotech enters into commercialization agreement with Advanz Pharma for proposed biosimilar to Xolair® (omalizumab)
Tuesday, February 07, 2023Alvotech a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide today announced that it has entered into an exclusive agreement with Advanz Pharma for the commercialization of AVT a pro...
Tonix Pharmaceuticals Announces Acquisition of Preclinical Infectious Disease Portfolio from Healion Bio, Inc.
Friday, February 03, 2023Tonix Pharmaceuticals Holding Corp a clinicalstage biopharmaceutical company today announced an agreement whereby Tonix has acquired all of the assets of Healion Bio Inc Healion including its entire portfolio of nextgeneration antiviral technology as...
Unicycive Announces Exclusive License and Development Agreement with Lotus for Renazorb in the Republic of Korea
Friday, February 03, 2023Unicycive Therapeutics Inc a clinical stage biotechnology company developing therapies for patients with kidney disease today announced that it has entered into an exclusive license agreement with Lotus Pharmaceutical a leading global pharmaceutical...
InterCure Announces the Termination of its Acquisition Agreement with Cann Pharmaceutical (dba Better)
Thursday, February 02, 2023InterCure Ltd announces that further to the merger agreement with Cann Pharmaceutical Ltd Better dated as of February pursuant to which and subject to its terms InterCure was to acquire of the issued and outstanding shares of Better the Agreement...
Adial Pharmaceuticals Enters Into Option Agreement for Sale of Purnovate Assets to Adenomed
Thursday, February 02, 2023Adial Pharmaceuticals Inc a clinicalstage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders today announced it has entered into an option agreement for the sale of the assets...
Fennec Pharmaceuticals Announces PEDMARK® (sodium thiosulfate injection) Receives Orphan Drug Exclusivity from U.S. FDA
Wednesday, February 01, 2023Fennec Pharmaceuticals Inc a commercial stage specialty pharmaceutical company today announced that the US Food and Drug Administration FDA has granted Orphan Drug Exclusivity to PEDMARK sodium thiosulfate injection which is indicated to reduce the r...
West Announces Three New Product Innovations at Pharmapack Europe
Wednesday, February 01, 2023West Pharmaceutical Services Inc a global leader in innovative solutions for injectable drug administration today announced participation at Pharmapack Europe in Paris France to showcase its leadership and expertise on industry challenges and trends...
Charles River Laboratories Acquires SAMDI Tech
Tuesday, January 31, 2023Charles River Laboratories International Inc announced today that it has acquired SAMDI Tech Inc a leading provider of highquality labelfree highthroughput screening HTS solutions for drug discovery research The acquisition marks the culmination of a...
